Cargando…

A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda

BACKGROUND: Peripheral arterial disease (PAD) has significant morbidity including limb loss. The prevalence of PAD in low- and middle-income countries ranges from 3-25% though the global burden is accepted to be near 6%. The objective of this pilot study was to estimate the prevalence of PAD and ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Denison Martin, K, Dockery, D, Harelimana, J, Ahishakiye, E, Licht, A, Nuenzweig, S, Allu, S, Cunningham, R, Ingabire, E, Izere, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597033/
http://dx.doi.org/10.1093/eurpub/ckad160.797
_version_ 1785125246351704064
author Denison Martin, K
Dockery, D
Harelimana, J
Ahishakiye, E
Licht, A
Nuenzweig, S
Allu, S
Cunningham, R
Ingabire, E
Izere, J
author_facet Denison Martin, K
Dockery, D
Harelimana, J
Ahishakiye, E
Licht, A
Nuenzweig, S
Allu, S
Cunningham, R
Ingabire, E
Izere, J
author_sort Denison Martin, K
collection PubMed
description BACKGROUND: Peripheral arterial disease (PAD) has significant morbidity including limb loss. The prevalence of PAD in low- and middle-income countries ranges from 3-25% though the global burden is accepted to be near 6%. The objective of this pilot study was to estimate the prevalence of PAD and associated risk factors in Kigali, Rwanda. METHODS: This is a multicenter, mixed-methods, cross-sectional study conducted at three health facilities in Kigali, Rwanda. Patients older than 40 years old presenting for non-emergent reasons at the clinics were eligible for participation in the study. An ankle-brachial index (ABI) was measured using the Unetixs Revo 1100/8 MHz probe for PAD screening. An ABI </=0.9 was the value diagnostic for PAD, and >1.3 was used for an inconclusive ABI. A self-reported survey was collected to determine demographics and medical history, including smoking status and medication use. RESULTS: A total of 861 participants were included in this study with an overall PAD positivity rate of 3.14%. Additionally, 166 patients (19.3%) had inconclusive ABIs. Patients who screened positive for PAD were significantly more likely to be older (63 vs 56, p = 0.009), of lower wealth indexes (p = 0.016), and were more likely to be current or former smokers (13 (48.1%) vs 217 (32.5%), p = 0.041) (Table 1). Patients with inconclusive ABIs were significantly more likely to be male (70 (42%) vs 140 (21%), p = <0.001), more likely to have chronic kidney disease (4 (2.4%) vs 2 (0.3%), p = 0.016), and more likely to be positive for human immunodeficiency virus (HIV) (44 (27%) vs 127 (19%), p = 0.041). There were also lower rates of DM and HTN in the inconclusive group but no differences in the diagnostic group. CONCLUSIONS: Our results revealed that the prevalence of PAD in Kigali, Rwanda, was similar to ranges quoted in the literature at 3.14%. Results hint that traditional risk factors such as DM and HTN may be less common amongst people with PAD in Rwanda. KEY MESSAGES: • The prevalence of peripheral artery disease (PAD) in Rwanda is similar to estimates in other LMICs. • Traditional risk factors such as diabetes and hypertension may play smaller roles in the etiology of peripheral artery disease (PAD) in Rwanda.
format Online
Article
Text
id pubmed-10597033
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105970332023-10-25 A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda Denison Martin, K Dockery, D Harelimana, J Ahishakiye, E Licht, A Nuenzweig, S Allu, S Cunningham, R Ingabire, E Izere, J Eur J Public Health Poster Walks BACKGROUND: Peripheral arterial disease (PAD) has significant morbidity including limb loss. The prevalence of PAD in low- and middle-income countries ranges from 3-25% though the global burden is accepted to be near 6%. The objective of this pilot study was to estimate the prevalence of PAD and associated risk factors in Kigali, Rwanda. METHODS: This is a multicenter, mixed-methods, cross-sectional study conducted at three health facilities in Kigali, Rwanda. Patients older than 40 years old presenting for non-emergent reasons at the clinics were eligible for participation in the study. An ankle-brachial index (ABI) was measured using the Unetixs Revo 1100/8 MHz probe for PAD screening. An ABI </=0.9 was the value diagnostic for PAD, and >1.3 was used for an inconclusive ABI. A self-reported survey was collected to determine demographics and medical history, including smoking status and medication use. RESULTS: A total of 861 participants were included in this study with an overall PAD positivity rate of 3.14%. Additionally, 166 patients (19.3%) had inconclusive ABIs. Patients who screened positive for PAD were significantly more likely to be older (63 vs 56, p = 0.009), of lower wealth indexes (p = 0.016), and were more likely to be current or former smokers (13 (48.1%) vs 217 (32.5%), p = 0.041) (Table 1). Patients with inconclusive ABIs were significantly more likely to be male (70 (42%) vs 140 (21%), p = <0.001), more likely to have chronic kidney disease (4 (2.4%) vs 2 (0.3%), p = 0.016), and more likely to be positive for human immunodeficiency virus (HIV) (44 (27%) vs 127 (19%), p = 0.041). There were also lower rates of DM and HTN in the inconclusive group but no differences in the diagnostic group. CONCLUSIONS: Our results revealed that the prevalence of PAD in Kigali, Rwanda, was similar to ranges quoted in the literature at 3.14%. Results hint that traditional risk factors such as DM and HTN may be less common amongst people with PAD in Rwanda. KEY MESSAGES: • The prevalence of peripheral artery disease (PAD) in Rwanda is similar to estimates in other LMICs. • Traditional risk factors such as diabetes and hypertension may play smaller roles in the etiology of peripheral artery disease (PAD) in Rwanda. Oxford University Press 2023-10-24 /pmc/articles/PMC10597033/ http://dx.doi.org/10.1093/eurpub/ckad160.797 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Walks
Denison Martin, K
Dockery, D
Harelimana, J
Ahishakiye, E
Licht, A
Nuenzweig, S
Allu, S
Cunningham, R
Ingabire, E
Izere, J
A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda
title A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda
title_full A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda
title_fullStr A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda
title_full_unstemmed A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda
title_short A Pilot Study on the Prevalence of Peripheral Arterial Disease in Kigali, Rwanda
title_sort pilot study on the prevalence of peripheral arterial disease in kigali, rwanda
topic Poster Walks
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597033/
http://dx.doi.org/10.1093/eurpub/ckad160.797
work_keys_str_mv AT denisonmartink apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT dockeryd apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT harelimanaj apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT ahishakiyee apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT lichta apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT nuenzweigs apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT allus apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT cunninghamr apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT ingabiree apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT izerej apilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT denisonmartink pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT dockeryd pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT harelimanaj pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT ahishakiyee pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT lichta pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT nuenzweigs pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT allus pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT cunninghamr pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT ingabiree pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda
AT izerej pilotstudyontheprevalenceofperipheralarterialdiseaseinkigalirwanda